FlashNews:
Why Follower Count Matters Less Than Ever
Private credit under strain as troubled loans swell
America and the politics of respect
Chainalysis sues US over $95M ICE contract with TRM Labs
Data of 54,000 wallet users leaked, CLARITY odds just 10%: Hodler’s Digest
Quick crossword No 17,560
Cryptic crossword No 30,087
France’s Top Court Blocks Social Media Ban for Under-15s
Why Founders Brick Was Built: Rethinking Modern Wealth Management
What Makes a Modern Investment Company Different From Traditional Financial Institutions?
Four ‘extraordinary’ Renaissance paintings stolen from Italian museum
Samsung Galaxy Z Fold8 and Galaxy Z Fold8 Ultra Review: The Right Shape
Astronomers Discover the Existence of a Black Hole Star
Veritron Compliance Group Launches To Address Growing Digital Compliance Crisis
Qixi Fest 2026 Celebrates Singapore’s Food Heritage
Fairmont Southampton Opens Palmetto Beach Club, Marking First Chapter in Resort’s Return
Ariana Grande leaves problems at home as her tour hits the UK
DataShyre Expands Consent Management for Ecommerce to Help Retailers Build Customer Trust and Drive Growth
DataShyre Expands Consent Management for Financial Services With Automated, Permissioned Data Governance
Business
Business News
Business Intelligence That Matters

Private credit under strain as troubled loans swell
This post was originally published on this site.FT analysis shows signals of stress in the market are back to levels last seen in 2017

America and the politics of respect
This post was originally published on this site.Issues won’t matter in the midterms as much as whether voters feel valued
More pain in private credit as JPMorgan reportedly tightening lending while a $33 bln fund sees heavy redemptions
The troubled private-credit industry was under further pressure after a report that JPMorgan Chase was tightening its lending criteria while a $33 billion fund was
Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.
Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are
Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute
Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking
The guards rise again: the force still shaping Iran
Should the regime survive, hardliners believe the IRGC’s influence will be ever greater
The bombing of Tehran — in maps and satellite images
Israeli and US strikes have targeted regime infrastructure and also struck civilian sites. Here are some of the key buildings hit
Qatar warns war will force Gulf to stop energy exports within weeks
Gas producer says it will take ‘weeks to months’ to restore deliveries after Iranian drone strike
Nvidia stops production of chips intended for Chinese market
US group moves production away from H200s to latest Vera Rubin products